Skip to main content
SOLESENCE, INC. logo

SOLESENCE, INC. — Investor Relations & Filings

Ticker · SLSN ISIN · US6300791018 US Manufacturing
Open in API
Filings indexed 1,012 across all filing types
Latest filing 2012-03-16 Director's Dealing
Country US United States of America
Listing US SLSN

About SOLESENCE, INC.

https://ir.solesence.com/

Solesence, Inc. is a developer and manufacturer specializing in mineral-based skincare and color cosmetics for partner brands. The company focuses on skin health through its proprietary and patented technologies, including the Active Stress Defense™ suite and Solésence Kleair™. These technologies are engineered to create highly effective, transparent, and aesthetically pleasing mineral sun protection (SPF) products. Solesence enables the creation of innovative textures and formats in skincare, sun care, and color cosmetics, offering both contract manufacturing and white-label product solutions to the beauty industry.

Recent filings

Filing Released Lang Actions
PRIMARY DOCUMENT
Director's Dealing
2012-03-16 English
PRIMARY DOCUMENT
Director's Dealing
2012-03-16 English
FORM 8-K FILING DOCUMENT
Delisting Announcement Classification · 100% confidence The document is a Form 8-K filing with the SEC, dated March 7, 2012, for Nanophase Technologies Corporation. It includes an Item 3.01 section titled 'Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing,' which discusses the company's voluntary delisting from the Nasdaq Capital Market and transfer to the OTCQB marketplace. The document is relatively short (3893 characters) and primarily serves as an official notice of the delisting event rather than a detailed report or financial statement. Therefore, it fits the category of a Delisting Announcement (DLST).
2012-03-07 English
FORM 8-K
Regulatory Filings Classification · 95% confidence The document is a Form 8-K filed with the SEC, which is a current report used to announce major events that shareholders should know about. The text specifically describes the entry into a definitive material agreement (a Mutual Cooperation Agreement) between Nanophase Technologies Corporation and C.I. Kasei Co., Ltd. It includes details about the agreement and references the full text of the agreement as an exhibit. There are no financial statements or quarterly/annual financial results presented, nor is this a proxy, earnings release, or management discussion. The document is an announcement of a material contract/agreement, which fits the category of a Regulatory Filing (RNS) as it does not fall into more specific categories like M&A or Capital/Financing Update. The document length is 3325 characters, which is relatively short and consistent with an 8-K filing announcing a material event. Therefore, the best classification is Regulatory Filings (RNS).
2012-01-20 English
PRIMARY DOCUMENT
Director's Dealing
2012-01-05 English
PRIMARY DOCUMENT
Director's Dealing
2011-12-23 English

Browse filings by year

22 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.